Insider · CIK 0001296549

Belldegrun Arie

Reports to the SEC for 11 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001296549

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-22	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+20K sh	—	—	20,000
2026-02-02	ALLOAllogene Therapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+263K sh	—	—	263,033
2026-02-02	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+930K sh	—	—	929,913
2025-08-26	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2.77M sh	$0.57	−$1.58M	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.6K sh	—	—	0
2025-06-20	Kronos Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−680K sh	$0.57	−$387K	0
2025-06-20	Kronos Bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34K sh	—	—	0
2025-01-24	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+1.31M sh	—	—	1,307,927
2025-01-24	ALLOAllogene Therapeutics, Inc.A Award	Director	AAward	+370K sh	—	—	2,236,816
2024-08-06	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-06-25	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2024-06-13	DNAGinkgo Bioworks Holdings, Inc. · Restricted Stock UnitsA Award	Director	AAward	+433K sh	—	—	432,900
2024-06-13	DNAGinkgo Bioworks Holdings, Inc. · Stock OptionA Award	Director	AAward	+571K sh	—	—	571,428
2024-06-12	DNAGinkgo Bioworks Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+105K sh	—	—	194,925
2024-06-12	DNAGinkgo Bioworks Holdings, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−105K sh	—	—	0
2024-05-16	ALLOAllogene Therapeutics, Inc.A Award	Director	AAward	+345K sh	$2.90	+$1M	539,867
2024-05-16	ALLOAllogene Therapeutics, Inc.P Purchase	Director	PPurchase	+1.72M sh	$2.90	+$5M	1,724,137
2024-01-25	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+749K sh	—	—	749,398
2024-01-25	ALLOAllogene Therapeutics, Inc.A Award	Director	AAward	+212K sh	—	—	1,866,859
2023-09-07	URGNUroGen Pharma Ltd. · Stock Option (right ot buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-06-22	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2023-06-16	DNAGinkgo Bioworks Holdings, Inc. · Stock OptionA Award	Director	AAward	+140K sh	—	—	139,860
2023-06-16	DNAGinkgo Bioworks Holdings, Inc. · Restricted Stock UnitsA Award	Director	AAward	+105K sh	—	—	105,263
2023-03-22	ALLOAllogene Therapeutics, Inc.A Award	Director	AAward	+1.28M sh	—	—	1,654,886
2023-03-22	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+995K sh	—	—	994,800
2022-09-14	URGNUroGen Pharma Ltd. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−160K sh	—	—	0
2022-09-14	URGNUroGen Pharma Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+160K sh	$5.00	+$800K	408,693
2022-08-31	URGNUroGen Pharma Ltd. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,241 sh	—	—	0
2022-08-31	URGNUroGen Pharma Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+3,241 sh	$5.00	+$16.2K	248,693
2022-06-22	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2022-06-10	DNAGinkgo Bioworks Holdings, Inc. · Stock OptionA Award	Director	AAward	+109K sh	—	—	108,516
2022-06-10	DNAGinkgo Bioworks Holdings, Inc.A Award	Director	AAward	+70.9K sh	—	—	89,662
2022-06-08	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-03-23	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1.46M sh	—	—	1,458,333
2022-03-14	ALLOAllogene Therapeutics, Inc.J Other	Director	JOther	+4.71M sh	—	—	4,710,120
2022-03-14	ALLOAllogene Therapeutics, Inc.J Other	Director	JOther	−4.71M sh	—	—	0
2022-03-14	ALLOAllogene Therapeutics, Inc.J Other	Director	JOther	−4.71M sh	—	—	0
2022-03-14	ALLOAllogene Therapeutics, Inc.J Other	Director	JOther	+4.71M sh	—	—	4,710,121
2022-01-12	ALLOAllogene Therapeutics, Inc.P Purchase	Director	PPurchase	+155K sh	$12.60	+$1.95M	195,039
2021-06-22	Kronos Bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20.6K sh	—	—	20,600
2021-06-07	URGNUroGen Pharma Ltd. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-05-24	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−379K sh	—	—	0
2021-05-24	ALLOAllogene Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+379K sh	$18.22	+$6.91M	583,034
2021-03-26	ALLOAllogene Therapeutics, Inc.A Award	Director	AAward	+53.6K sh	—	—	203,968
2021-03-26	URGNUroGen Pharma Ltd. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,241 sh	—	—	0
2021-03-26	URGNUroGen Pharma Ltd.M Exercise/Conversion	Director	MExercise/Conversion	+3,241 sh	$5.00	+$16.2K	245,452
2021-03-26	ALLOAllogene Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+199K sh	—	—	199,223

Recent filings

Accepted (ET)
Jun 244
Belldegrun Arie0001437749-26-021509
SEC(opens sec.gov)
Feb 44
Belldegrun Arie0001296549-26-000002
SEC(opens sec.gov)
Aug 274
Belldegrun Arie0001437749-25-027877
SEC(opens sec.gov)
Jun 204
Belldegrun Arie0001415889-25-017834
SEC(opens sec.gov)
Jan 284
Belldegrun Arie0001737287-25-000005
SEC(opens sec.gov)
Aug 84
Belldegrun Arie0001437749-24-025299
SEC(opens sec.gov)
Jun 264
Belldegrun Arie0001415889-24-018230
SEC(opens sec.gov)
Jun 144
Belldegrun Arie0001127602-24-018717
SEC(opens sec.gov)
May 204
Belldegrun Arie0001737287-24-000042
SEC(opens sec.gov)

Companies

Address

400 ALEXANDER PARK DRIVE

PRINCETON, NJ, 08540